Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation

Published:2018-09-25 Issue:12 Volume:15 Page:5521-5533
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Huang Zhengwei¹,Huang Ying¹,Ma Cheng¹,Ma Xiangyu²,Zhang Xuejuan¹³,Lin Ling¹,Zhao Ziyu¹,Pan Xin¹^ORCID,Wu Chuanbin¹

Affiliation:

1. School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006 Guangdong, P. R. China

2. College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712, United States

3. Institute for Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, P.R. China

Funder

State Administration of Foreign Experts Affairs

Ministry of Education of the People's Republic of China

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00668

Reference65 articles.

1. Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles

2. How can nanoparticles contribute to antituberculosis therapy?

3. Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor

4. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation

5. Mucus and Cell-Penetrating Nanoparticles Embedded in Nano-into-Micro Formulations for Pulmonary Delivery of Ivacaftor in Patients with Cystic Fibrosis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract;International Journal of Molecular Sciences;2022-02-22

2. Major difference in particle size, minor difference in release profile: a case study of solid lipid nanoparticles;Pharmaceutical Development and Technology;2021-11-07

3. Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after Pulmonary Administration;ACS Applied Materials & Interfaces;2021-01-13

4. Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery;Journal of Controlled Release;2020-09

5. Enhancing Targeted Cancer Treatment by Combining Hyperthermia and Radiotherapy Using Mn–Zn Ferrite Magnetic Nanoparticles;ACS Biomaterials Science & Engineering;2020-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3